The use of vaccines in South American foot-and-mouth disease eradication programmes
- PMID: 15742616
The use of vaccines in South American foot-and-mouth disease eradication programmes
Abstract
Since the beginning of organized campaigns in the 1960s, vaccination has been a major component of national FMD control and eradication programmes in South America. Aqueous vaccines were used in the 1960s and 1970s, and the introduction of oil vaccines in the mid 1980s helped to decrease endemism. Bi- and trivalent FMD vaccine production increased from 266 thousand doses in 1967 to 580 million doses in 2002. Currently, over 200 million cattle are vaccinated twice yearly throughout the continent. This massive vaccination programme, along with outbreak and animal movement control, helped eradicate FMD in sizeable areas in the 1990s. Outbreaks in the Southern Cone during 2000/2001 were curbed mostly by repeated massive vaccination of cattle. The Hemispheric FMD Eradication Plan, with its end date of 2009, relies on cyclic vaccinations as a major instrument. Vaccination as the major component will continue until when?
Similar articles
-
Vaccines and foot-and-mouth disease eradication in South America.Dev Biol (Basel). 2003;114:67-77. Dev Biol (Basel). 2003. PMID: 14677678 Review.
-
Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.Expert Rev Vaccines. 2005 Dec;4(6):903-13. doi: 10.1586/14760584.4.6.903. Expert Rev Vaccines. 2005. PMID: 16372885 Review.
-
Control of foot and mouth disease: the experience of the Americas.Rev Sci Tech. 2002 Dec;21(3):695-8, 689-94. Rev Sci Tech. 2002. PMID: 12523707 Review. English, Spanish.
-
Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.Vaccine. 2005 Dec 30;23(50):5775-82. doi: 10.1016/j.vaccine.2005.07.043. Epub 2005 Aug 8. Vaccine. 2005. PMID: 16153756
-
Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.Dev Biol (Basel). 2004;119:267-72. Dev Biol (Basel). 2004. PMID: 15742638 Review.
Cited by
-
Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.Virus Genes. 2007 Oct;35(2):347-57. doi: 10.1007/s11262-007-0105-0. Epub 2007 May 12. Virus Genes. 2007. PMID: 17497212
-
Elimination of foot-and-mouth disease in South America: lessons and challenges.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120381. doi: 10.1098/rstb.2012.0381. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798699 Free PMC article.
-
Maternally Derived Antibodies to Foot-and-Mouth Disease Virus Modulate the Antigenic Specificity of Humoral Responses in Vaccinated Cattle.Vaccines (Basel). 2023 Dec 13;11(12):1844. doi: 10.3390/vaccines11121844. Vaccines (Basel). 2023. PMID: 38140247 Free PMC article.
-
Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.Vaccine. 2015 Feb 4;33(6):805-11. doi: 10.1016/j.vaccine.2014.12.010. Epub 2014 Dec 17. Vaccine. 2015. PMID: 25528523 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical